β-Amyloid-mediated vasoactivity and vascular endothelial damage
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Deposits of beta-amyloid are apparent in ageing and Alzheimer's disease, but the role of this peptide in neurodegeneration is unclear. The free-radical theory of ageing may also account for Alzheimer-type degeneration and consequently links between free-radical generation and beta-amyloid have been sought. We demonstrate here that beta-amyloid interacts with endothelial cells on blood vessels to produce and excess of superoxide radicals, with attendant alterations in endothelial structure and function. The superoxide radical can scavenge endothelium-derived relaxing factor and produce potent oxidizing agents, which can cause lipid peroxidation and other degenerative changes. The alterations in vascular tone and endothelial damage are prevented by the oxygen-radical-scavenging enzyme superoxide dismutase. These observations suggest a normal vasoactive role for beta-amyloid as well as a mechanism by which beta-amyloid may play a role in vascular abnormalities and neurodegeneration mediated by free radicals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Aβ is a potent vasoconstrictor113,114 and suppresses endothelium-dependent responses, functional hyperemia, and cerebrovascular autoregulation.115–117”
In the citing paper
“As shown by pharmacological studies, these high concentrations of A b may impair local BBB integrity (58-59), which in turn may contaminate brain ISF with blood and/or plasma that possesses A b -degrading activity (48)”
From Clearance of Alzheimer’s amyloid-β1-40 peptide from brain by LDL receptor–related protein-1 at the blood-brain barrier (2000) · cites this paper as [59]
In the citing paper
“Aβ4 constrict isolated cerebral and systemic blood vessels (Niwa et al., 2001; Paris et al., 2003; Thomas et al., 1996)”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Thomas et al., 1996
Citations
Cites
Furchgott, R. F., & Zawadzki, J. V. (1980) · Nature · doi:10.1038/288373a0 · Cited by 12,064
Lipton, S. A., Choi, Y.-B., Pan, Z.-H., Lei, S. Z., Chen, H.-S. V., Sucher, N. J., Loscalzo, J., Singel, D. J., & Stamler, J. S. (1993) · Nature · doi:10.1038/364626a0 · Cited by 2,433
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)91209-9 · Cited by 1,693
β-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease
Mattson, M. P., Barger, S. W., Cheng, B., Lieberburg, I., Smith-Swintosky, V. L., & Rydel, R. E. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90009-b · Cited by 518
PGH synthase and lipoxygenase generate superoxide in the presence of NADH or NADPH.
Kukreja, R. C., Kontos, H. A., Hess, M. L., & Ellis, E. F. (1986) · Circulation Research · doi:10.1161/01.res.59.6.612 · Cited by 487
Bu�e, L., Hof, P. R., Bouras, C., Delacourte, A., Perl, D. P., Morrison, J. H., & Fillit, H. M. (1994) · Acta Neuropathologica · doi:10.1007/bf00294173 · Cited by 334
Scholz, W. (1938) · Zeitschrift für die gesamte Neurologie und Psychiatrie · doi:10.1007/bf02890989 · Cited by 180
Soluble β-Amyloid Induction of Alzheimer's Phenotype for Human Fibroblast K + Channels
Etcheberrigaray, R., Ito, E., Kim, C. S., & Alkon, D. L. (1994) · Science · doi:10.1126/science.8146663 · Cited by 167
Untangling the pathophysio-chemistry of β-amyloid
Mattson, M. P. (1995) · Nature Structural & Molecular Biology · doi:10.1038/nsb1195-926 · Cited by 41
Research works printed but not linked: 2
- Davignon, J., Gregg, R. & Sing, C. Atherosclerosis 8, 1–21 (1988).
- Tomimoto, H., Nakimura, S., Wakita, H., Kimura, J. & Akiguchi, I. J. Cereb. Blood Flow Metab. 14, 563–573 (1994).
Cited by
Items 301–400 of 710
de la Monte, S. M., Lu, B.-X., Sohn, Y. K., ETIENNE, D., Kraft, J., Ganju, N., & Wands, J. R. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00108-6 · Cited by 62
Vascular and Metabolic Factors in Alzheimer’s Disease and Related Dementias: Introduction
Iadecola, C. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0319-y · Cited by 66
“Ab is a potent vasoconstrictor (Niwa et al. 2001; Thomas et al. 1996), reduces resting CBF (Niwa et al.”
Pathophysiological Links Among Hypertension and Alzheimer’s Disease
Carnevale, D., Perrotta, M., Lembo, G., & Trimarco, B. (2015) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-015-0108-1 · Cited by 61
Shin, E. S., Park, J., Shin, J., Cho, D., Cho, S. Y., Shin, D. W., Ham, M., Kim, J. B., & Lee, T. R. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.02.030 · Cited by 58
Hypertension and Related Factors in the Etiology of Alzheimer's Disease
SKOOG, I., & GUSTAFSON, D. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04796.x · Cited by 57
Krucker, T., Schuler, A., Meyer, E. P., Staufenbiel, M., & Beckmann, N. (2004) · Neurological Research · doi:10.1179/016164104225016281 · Cited by 56
Loane, D. J., Washington, P. M., Vardanian, L., Pocivavsek, A., Hoe, H.-S., Duff, K. E., Cernak, I., Rebeck, G. W., Faden, A. I., & Burns, M. P. (2011) · Journal of Neurotrauma · doi:10.1089/neu.2010.1595 · Cited by 57
“It is implicated as the primary neurotoxic factor in Alzheimer’s disease pathogenesis, and is toxic to neurons (Yankner et al., 1989), endothelial cells (Thomas et al., 1996), astrocytes (Brera et al., 2000), and vascular smooth muscle cells (Davis-Salinas et al., 1995).”
BackgroundGlial and endothelial blood-retinal barrier responses to amyloid-β in the neural retina of the rat
Anderson, P. J., Watts, H., Hille, C., Philpott, K., Clark, P., Gentleman, M. C. S., & Jen, L.-S. (2008) · Clinical ophthalmology · doi:10.2147/opth.s3967 · Cited by 62
“A β constricted isolated aortas and signifi cantly reduced the vasodilatory effect of acetylcholine (Thomas et al 1996).”
Expression and Processing of Amyloid Precursor Protein in Vascular Endothelium
d'Uscio, L. V., He, T., & Katusic, Z. S. (2017) · Physiology · doi:10.1152/physiol.00021.2016 · Cited by 57
Olichney, J., Ellis, R. J., Katzman, R., Sabbagh, M. N., & Hansen, L. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48511.x · Cited by 57
Microvascular damage and platelet abnormalities in early Alzheimer's disease
Borroni, B., Akkawi, N. M., Martini, G., Colciaghi, F., Prometti, P., Rozzini, L., Luca, M. D., Lenzi, G. L., Romanelli, G., Caimi, L., et al. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00289-7 · Cited by 57
Are Alzheimer’s disease, hypertension, and cerebrocapillary damage related?☆
Farkas, E., de Vos, R. A. I., Steur, E. N. H. J., & Luiten, P. G. M. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00122-6 · Cited by 61
Deininger, M. H., Fimmen, B. A., Thal, D. R., Schluesener, H. J., & Meyermann, R. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-24-10621.2002 · Cited by 53
“-amyloid interacts with endothelial cells on blood vessels to produce an excess of superoxide radicals, with attendant alterations in endothelial structure and function (Thomas et al., 1996).”
BackgroundStimulated release of the β-amyloid protein of Alzheimer's disease by normal human platelets
Smith, C. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00738-6 · Cited by 56
How reliable is cerebral blood flow to map changes in neuronal activity?
Lecrux, C., Bourourou, M., & Hamel, E. (2019) · Autonomic Neuroscience · doi:10.1016/j.autneu.2019.01.005 · Cited by 50
Stroke Pattern Interpretation: The Variability of Hypertensive versus Amyloid Angiopathy Hemorrhage
Lang, E. W., Ya, Z. R., Preul, C., Hugo, H., Hempelmann, R. G., Buhl, R. M., Barth, H., Klinge, H., & Mehdorn, H. M. (2001) · Cerebrovascular Diseases · doi:10.1159/000047691 · Cited by 58
“In our series 2 patients (5p), who also had a history of HTN, had cerebellar hemorrhages in CAA. In HTN, however, 17p had cerebellar hemorrhage in our series. It is difficult, if not entirely impossible, to distinguish CAA-related ICH from HTN-related ICH on CT in cerebellar hemorrhages. Size There was a significant d…”
Physiological levels of amyloid peptides stimulate the angiogenic response through FGF‐2
Cantara, S., Donnini, S., Morbidelli, L., Giachetti, A., Schulz, R., Memo, M., & Ziche, M. (2004) · The FASEB Journal · doi:10.1096/fj.04-2114fje · Cited by 53
Retractedde la Monte, S. M., Sohn, Y. K., ETIENNE, D., Kraft, J., & Wands, J. R. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06351.x · Cited by 59
Ikonomović, M. D., Mi, Z., & Abrahamson, E. E. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.11.003 · Cited by 56
A Vascular Connection to Alzheimer's Disease
Rhodin, J. A. G., & Thomas, T. R. (2001) · Microcirculation · doi:10.1080/713774033 · Cited by 53
Self-citation1–42 β-Amyloid peptide requires PDK1/nPKC/Rac 1 pathway to induce neuronal death
Manterola, L., Hernando-Rodríguez, M., Ruiz, A., Apraiz, A., Arrizabalaga, O., Vellón, L., Alberdi, E., Cavaliere, F., Lacerda, H. M., Jimenez, S., et al. (2013) · Translational Psychiatry · doi:10.1038/tp.2012.147 · Cited by 51
Muñoz, F. J., Opazo, C., Gil‐Gómez, G., Tapia, G., Fernández, V., Valverde, M. A., & Inestrosa, N. C. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03081.2002 · Cited by 58
“Oxidative stress has been proposed as one of the possible mechanisms of A -mediated toxicity in both neuronal (Calderón et al., 1999) and endothelial (Thomas et al., 1996) cells.”
BackgroundInfluentialTipping points in neurodegeneration
Simons, M., Levin, J., & Dichgans, M. (2023) · Neuron · doi:10.1016/j.neuron.2023.05.031 · Cited by 50
Hung, V. K., Yeung, P. K., Lai, A. K., Ho, M. C., Lo, A. C., Chan, K. C., Wu, E. X., Chung, S. S., Cheung, C. W., & Chung, S. K. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.109 · Cited by 48
Reproductive Hormones Modulate Oxidative Stress in Alzheimer's Disease
Barron, A. M., Fuller, S. J., Verdile, G., & Martins, R. N. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.2047 · Cited by 54
Gottesman, R. F., Mosley, T. H., Knopman, D. S., Hao, Q., Wong, D., Wagenknecht, L. E., Hughes, T. M., Qiao, Y., Dearborn, J., & Wasserman, B. A. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2019.4339 · Cited by 46
Inoue, T., Saniabadi, A. R., Matsunaga, R., Hoshi, K., Yaguchi, I., & Morooka, S. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00098-7 · Cited by 53
Endothelin receptor antagonists: Potential in Alzheimer's disease
Palmer, J. C., & Love, S. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.12.008 · Cited by 52
Current Update on Synopsis of miRNA Dysregulation in Neurological Disorders
Kamal, M. A., Mushtaq, G., & Greig, N. H. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527314666150225143637 · Cited by 58
Molecular and biochemical trajectories from diabetes to Alzheimer’s disease: A critical appraisal
Sandhir, R., & Gupta, S. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i12.1223 · Cited by 49
Elevated circulating amyloid concentrations in obesity and diabetes promote vascular dysfunction
Meakin, P. J., Coull, B. M., Tuharska, Z., McCaffery, C., Akoumianakis, I., Antoniades, C., Brown, J., Griffin, K. J., Platt, F., Ozber, C. H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci122237 · Cited by 22
Kouznetsova, E., Klingner, M., Sorger, D., Sabri, O., Großmann, U., Steinbach, J., Scheunemann, M., & Schliebs, R. (2006) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2005.11.011 · Cited by 48
“Moreover, in culture b-amyloid has been shown to be toxic to endothelial cells (Thomas et al., 1996).”
BackgroundApolipoprotein e ϵ4 and the risk of unfavorable outcome after aneurysmal subarachnoid hemorrhage
Tang, J., Zhao, J., Zhao, Y., Wang, S., Chen, B., & Zeng, W. (2003) · Surgical Neurology · doi:10.1016/s0090-3019(03)00323-9 · Cited by 51
Lethem, R., & Orrell, M. W. (1997) · The Lancet · doi:10.1016/s0140-6736(05)62409-9 · Cited by 49
Endothelial leakiness elicited by amyloid protein aggregation
Li, Y., Ni, N., Lee, M., Wei, W., Andrikopoulos, N., Käkinen, A., Davis, T. P., Song, Y., Ding, F., Leong, D. T., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-44814-1 · Cited by 55
“…14 , the exact cause of cerebral vascular damage and their relationship with the development of AD remain unclear, with ROS production, in fl ammation, and the physical breakdown of tight junctions implicated as causative instigated by A β , Tau and apolipoprotein E, among others 14,15,17,21 – 23 .”
BackgroundMethodAPOE genotype predicts AD and other dementia but not ischemic cerebrovascular disease
Frikke–Schmidt, R., Nordestgaard, B. G., Thudium, D., Moes Grønholdt, M.-L., & Tybjærg–Hansen, A. (2001) · Neurology · doi:10.1212/wnl.56.2.194 · Cited by 47
Walia, V., Kaushik, D., Mittal, V., Kumar, K., Verma, R., Parashar, J., Akter, R., Rahman, M. H., Bhatia, S., Al-Harrasi, A., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02617-1 · Cited by 47
Zinc and its effects on oxidative stress in Alzheimer’s disease
Yuan, Y., Niu, F., Liu, Y., & Lu, N. (2014) · Neurological Sciences · doi:10.1007/s10072-014-1668-x · Cited by 50
Impaired Peripheral Endothelial Microvascular Responsiveness in Alzheimer's Disease
Khalil, Z., LoGiudice, D., Khodr, B., Maruff, P., & Masters, C. (2007) · Journal of Alzheimer's Disease · doi:10.3233/jad-2007-11106 · Cited by 47
“It has been shown that the effects of amyloid β are almost instantaneous, requiring exposure times of less than one minute [9,19,21,32,39].”
BackgroundReviewGenetics, lifestyle and the roles of amyloid β and oxidative stress in Alzheimer’s disease
Veurink, G., Fuller, S. J., Atwood, C. S., & Martins, R. N. (2003) · Annals of Human Biology · doi:10.1080/03014460310001620144 · Cited by 48
“It also has been demonstrated that Ab induces lipid peroxidation (Butterfield et al. 1994), and that Ab can cause excess production of superoxide radicals by interaction with vascular endothelial cells (Thomas et al. 1996).”
BackgroundMixed dementia: Neglected clinical entity or nosographic artifice?
Fierini, F. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.116662 · Cited by 50
CD36 – A novel molecular target in the neurovascular unit
Ioghen, O., Chițoiu, L., Gherghiceanu, M., Ceafalan, L. C., & Hinescu, M. E. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15147 · Cited by 47
Slater, C. L., & Wang, Q. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.397 · Cited by 50
Gaertner, R. F., Wyss-Coray, T., Von Euw, D., Lesné, S., Vivien, D., & Lacombe, P. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.11.008 · Cited by 46
β-Amyloid(1-40)-induced neurodegeneration in the rat hippocampal neurons of the CA1 subfield
Miguel-Hidalgo, J. J., & Cacabelos, R. (1998) · Acta Neuropathologica · doi:10.1007/s004010050825 · Cited by 48
“Both views are compatible since common mechanisms such as intracellular calcium destabilization [1, 23] and oxidative stress [2, 27, 36 ] appear to mediate Aβ neurotoxicity.”
Vaisi‐Raygani, A., Rahimi, Z., Tavilani, H., & Pourmotabbed, T. (2009) · Molecular Biology Reports · doi:10.1007/s11033-009-9666-4 · Cited by 45
Jiang, T., Wang, L., Zhang, S., Sun, P., Ding, C., Chu, Y., & Zhou, P. (2011) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2011.07.059 · Cited by 50
Cataldi, M. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311030004 · Cited by 54
Haglund, M., Kalaria, R. N., Slade, J. Y., & Englund, E. M. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0054-z · Cited by 50
Pericytes: Problems and Promises for CNS Repair
Laredo, F., Plebanski, J., & Tedeschi, A. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00546 · Cited by 44
The biochemical aftermath of anti-amyloid immunotherapy
Maarouf, C. L., Daugs, I. D., Kokjohn, T. A., Kalback, W. M., Patton, R. L., Luehrs, D. C., Masliah, E., Nicoll, J. A., Sabbagh, M. N., Beach, T. G., et al. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-39 · Cited by 43
Yang, D., Yeh, C.-H., Chen, S., Xu, J., & Hsu, C. Y. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.06.001 · Cited by 43
“Ah is a key mediator of neuronal degeneration in AD (Selkoe, 1991) and may also contribute to cerebrovascular pathology in AD brains (Thomas et al., 1996).”
BackgroundOLICHNEY, J. M., HANSEN, L. A., LEE, J. H., HOFSTETTER, C. R., KATZMAN, R., & THAL, L. J. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06360.x · Cited by 43
Cerebral amyloid angiopathy impact on endothelium
Grinberg, L. T., Korczyn, A. D., & Heinsen, H. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.08.005 · Cited by 39
“Indeed, application of exogenous Aβ caused endotheliumdependent vasoconstriction in normal blood vessels ex vivo (Thomas et al., 1996; Townsend et al., 2002).”
Bürger, S., Noack, M., Kirazov, L. P., Kirazov, E. P., Naydenov, C. L., Kouznetsova, E., Yafai, Y., & Schliebs, R. (2009) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2009.06.011 · Cited by 42
“Cerebrovascular pathology such as cerebral amyloid angio- pathy and endothelial degeneration have been reported in many Alzheimer cases (De la Torre, 2002; Kalaria, 2000; Soffer, 2006; Thomas et al., 1996).”
BackgroundReactive Oxygen Species in Diabetes-induced Vascular Damage, Stroke, and Alzheimer's Disease
Muhammad, S., Bierhaus, A., & Schwaninger, M. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-0982 · Cited by 41
“Indeed, Aβ modulates vascular tone in vitro and the effect is mediated by free radicals [84].”
BackgroundDrago, D., Folin, M., Baiguera, S., Tognon, G., Ricchelli, F., & Zatta, P. F. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-11107 · Cited by 45
Vascular mTOR-dependent mechanisms linking the control of aging to Alzheimer's disease
Galvan, V., & Hart, M. J. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.11.010 · Cited by 40
Scott, J. A., Braskie, M. N., Tosun, D., Maillard, P., Thompson, P. M., Weiner, M., DeCarli, C., & Carmichael, O. T. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.08.014 · Cited by 39
“However, cerebral amyloidosis can also interfere with perfusion of the brain by damaging perivascular spaces among other processes (Thomas et al., 1996).”
Drake, J., Initiative, A. D. N., Chambers, A. B., Ott, B. R., & Daiello, L. A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-200759 · Cited by 45
A genome-wide association meta-analysis of plasma Aβ peptides concentrations in the elderly
Chouraki, V. A., de Bruijn, R. F. A. G., Chapuis, J., Bis, J. C., Reitz, C., Schraen‐Maschke, S., Ibrahim‐Verbaas, C. A., Grenier‐Boley, B., Delay, C., Rogers, R. S., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.185 · Cited by 44
Alzheimer's Disease Modeling: Ups, Downs, and Perspectives for Human Induced Pluripotent Stem Cells
Wojda, U., & Kuznicki, J. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-121984 · Cited by 39
“The release of A by activated platelets appears to be responsible for A deposition in the walls of blood vessels, which in turn may lead to angiopathy in AD [165, 166].”
Induction of CD40 on human endothelial cells by Alzheimer’s β-amyloid peptides
Tan, J., Town, T., Suo, Z., Wu, Y., Song, S., Kundtz, A., Kroeger, J. L., Humphrey, J., Crawford, F., & MULLAN, M. J. (1999) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00122-7 · Cited by 40
Self-citationGold, G., Giannakopoulos, P., & Bouras, C. (1998) · European Neurology · doi:10.1159/000007968 · Cited by 41
Rhodin, J. A. G., Thomas, T. N., Clark, L. C., Garces, A. H., & Bryant, M. (2003) · Journal of Alzheimer s Disease · doi:10.3233/jad-2003-5403 · Cited by 42
Self-citationThe vascular contribution of apolipoprotein E to Alzheimer’s disease
Chen, F., Zhao, J., Meng, F., He, F., Ni, J., & Fu, Y. (2024) · Brain · doi:10.1093/brain/awae156 · Cited by 41
Plasma Aβ (Amyloid-β) Levels and Severity and Progression of Small Vessel Disease
van Leijsen, E. M. C., Kuiperij, H. B., Kersten, I., Bergkamp, M. I., van Uden, I. W. M., Vanderstichele, H., Stoops, E., Claassen, J. A. H. R., van Dijk, E. J., de Leeuw, F., et al. (2018) · Stroke · doi:10.1161/strokeaha.117.019810 · Cited by 43
Blood-Brain Barrier Disruption: A Common Driver of Central Nervous System Diseases
Segura‐Collar, B., Mata-Martínez, P., Hernández‐Laín, A., Gómez, P. S., & Gargini, R. (2021) · The Neuroscientist · doi:10.1177/1073858420985838 · Cited by 43
Austin, S. A., Sens, M. A., & Combs, C. K. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3107-09.2009 · Cited by 40
“…APP proteolytic fragments have direct ligand-type effects on endothelial cells resulting in dysfunction relevant to AD and cerebrovascular disease and have not attempted to readdress that biology in this study (Thomas et al., 1996; Iadecola et al., 1999; Price et al., 2001; Elesber et al., 2006).”
BackgroundEvered, L. A., SILBERT, B. S., Scott, D. A., Maruff, P. T., Laughton, K. M., Volitakis, I., Cowie, T., Cherny, R. A., Masters, C. L., & Li, Q. (2009) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2009.07.003 · Cited by 39
Samarasekera, N., Rodrigues, M. A., Toh, P. S., & Salman, R. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180923 · Cited by 45
BERGAMASCHINI, L., CANZIANI, S., BOTTASSO, B., CUGNO, M., BRAIDOTTI, P., & AGOSTONI, A. (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1999.00835.x · Cited by 39
Kimchi, E. Y., Kajdasz, S., Bacskai, B. J., & Hyman, B. T. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.3.274 · Cited by 39
Coughlan, C. M., & Breen, K. C. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00036-x · Cited by 44
Atherosclerosis and Neurodegeneration: Unexpected Conspirators in Alzheimer’s Dementia
Iadecola, C. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000102660.99744.85 · Cited by 42
Roy, S. S., & Rauk, A. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2004.08.031 · Cited by 43
“[81] Thomas T, Thomas G, McLendon C, Sutton T, Mullan M.”
BackgroundPalmer, J. C., Kehoe, P. G., & Love, S. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01084.x · Cited by 38
Linking vascular disorders and Alzheimer's disease: Potential involvement of BACE1
Cole, S. L., & Vassar, R. J. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.12.012 · Cited by 43
“Furthermore, superfuion of the neocortex with A led to deficits in hyperemia n wild type mice and previous studies examining the effects f A on isolated vessels add further support for the vascular ffects of this peptide (Thomas et al., 1996; Crawford et al., 998).”
Peripheral Blood Abnormalities in Alzheimer Disease: Evidence for Early Endothelial Dysfunction
Borroni, B., Volpi, R., Martini, G., Del Bono, R., Archetti, S., Colciaghi, F., Akkawi, N. M., Di Luca, M., Romanelli, G., Caimi, L., et al. (2002) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200207000-00004 · Cited by 39
“It has been shown that cerebrovascular changes parallel A deposition, suggesting that vascular damage is involved not only in the pathogenesis of vascular dementia but also in the development of AD (Thomas et al., 1996).”
BackgroundMattson, M. P., Furukawa, K., Bruce‐Keller, A. J., Mark, R. J., & Blanc, E. M. (1997) · Humana Press eBooks · doi:10.1007/978-1-59259-471-9_8 · Cited by 41
Paris, D., Town, T., Parker, T. A., Humphrey, J., & MULLAN, M. J. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00764-2 · Cited by 39
Self-citationAβ Vasoactivity: An Inflammatory Reaction
Paris, D., Town, T., Parker, T. A., Humphrey, J., & MULLAN, M. J. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06355.x · Cited by 44
Self-citationAntihypertensive agents for aging patients who are at risk for cognitive dysfunction
Hajjar, I. M., Keown, M., & Frost, B. (2005) · Current Hypertension Reports · doi:10.1007/s11906-005-0043-y · Cited by 38
Lu, X.-L., Liu, J., Wu, Q., Long, S., Zheng, M., Yao, X.-L., Ren, H., Wang, Y., Su, W., Cheung, R. T. F., et al. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.03.030 · Cited by 37
“Deposition of Aß40 damages endothelium, and causes distortion and occlusion of capillaries (Thomas et al., 1996), thereby compromising the normal function of cerebral blood vessels.”
BackgroundAmyloid-β Peptides Activate α 1 -Adrenergic Cardiovascular Receptors
Haase, N., Herse, F., Spallek, B., Haase, H., Morano, I., Qadri, F., Szijártó, I. A., Rohm, I., Yilmaz, A., Warrington, J. P., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01348 · Cited by 36
“Aβ has been identified in media and adventitia of small arteries and capillaries of cerebral and peripheral vessels earlier.(11,13,21) Investigators have proposed that vascular dysfunction is an early component of AD pathology.”
BackgroundRole of Peroxynitrite in the Vasoactive and Cytotoxic Effects of Alzheimer's β-Amyloid1–40Peptide
Paris, D., Parker, T. A., Town, T., Suo, Z., Fang, C., Humphrey, J., Crawford, F., & MULLAN, M. J. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6828 · Cited by 39
Self-citationRegional associations of white matter hyperintensities and early cortical amyloid pathology
Lorenzini, L., Ansems, L. T., Lopes Alves, I., Ingala, S., Vállez García, D., Tomassen, J., Sudre, C., Salvadó, G., Shekari, M., Operto, G., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac150 · Cited by 36
Lorenzini, L., Maranzano, A., Ingala, S., Collij, L. E., Tranfa, M., Blennow, K., Perri, C. D., Foley, C., Fox, N. C., Frisoni, G. B., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000209801 · Cited by 42
Park, E., Li, L. Y., He, C., Abbasi, A. Z., Ahmed, T., Foltz, W. D., O'Flaherty, R. M., Zain, M., Bonin, R. P., Rauth, A. M., et al. (2023) · Advanced Science · doi:10.1002/advs.202207238 · Cited by 43
Plasma Aβ, homocysteine, and cognition: The Vitamin Intervention for Stroke Prevention (VISP) trial
Viswanathan, A., Raj, S., Greenberg, S. M., Stampfer, M., Campbell, S., Hyman, B. T., & Irizarry, M. C. (2009) · Neurology · doi:10.1212/01.wnl.0000339486.63862.db · Cited by 36
Nitric oxide synthase gene polymorphisms in Alzheimer's disease and dementia with Lewy bodies
Singleton, A., Gibson, A. M., McKeith, I. G., Ballard, C. G., Edwardson, J. A., & Morris, C. M. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01694-9 · Cited by 38
Zlokovic, B. (1997) · Neurobiology of Disease · doi:10.1006/nbdi.1997.0134 · Cited by 34
“Regardless of the fact that the BBB could be a primary target for Ab-induced endothelial cell injury as are neurons and microglia (Thomas et al., 1996; Yan et al., 1996; Khoury et al., 1996), we have shown that specific binding of Ab to brain endothelium can trigger at least one other process.”
BackgroundKim, H., Kim, C., Seo, S. W., Na, D. L., Kim, H. J., Kang, M., Shin, H.-Y., Cho, S. K., Park, S. E., Lee, J., et al. (2014) · International Psychogeriatrics · doi:10.1017/s1041610214001744 · Cited by 36
“…for essential brain nutrients, such as vitamin B6, vitamin B12, vitamin C, vitamin E, β-carotene, and folate, which may lead to cerebrovascular disease (Boushey et al., 1995; Gonzalez-Gross et al., 2001) and AD changes (Thomas et al., 1996) through increased oxidative stress (Thomas et al., 1996).”
BackgroundWhy therapies for Alzheimer’s disease do not work: Do we have consensus over the path to follow?
Amtul, Z. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.09.003 · Cited by 39
‘Alzheimer-like’ pathology in a murine model of arterial hypertension
Carnevale, D., & Lembo, G. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390939 · Cited by 34
Anfuso, C. D., Assero, G., Lupo, G., Nicotra, A., Cannavò, G., Strosznajder, R. P., Rapisarda, P., Pluta, R. M., & Alberghina, M. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2004.09.006 · Cited by 36
FGF-2 overexpression opposes the beta amyloid toxic injuries to the vascular endothelium
Donnini, S., Cantara, S., Morbidelli, L., Giachetti, A., & Ziche, M. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401803 · Cited by 35
Chen, S., Lee, J., Zeng, C., Chen, H., Hsu, C. Y., & Xu, J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03774.x · Cited by 34
“1998), Ab is toxic to a variety of brain-derived cells, including endothelial cells (Thomas et al. 1996; Huang et al. 1998), vascular smooth muscle cells (Kawai et al.”
BackgroundMitochondrial mechanisms in amyloid beta peptide-induced cerebrovascular degeneration
Hsu, M., Sheu, J., Lin, C., Shen, M., & Hsu, C. Y. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.08.003 · Cited by 39
Gren, M., Shahim, P., Lautner, R., Wilson, D. H., Andréasson, U., Norgren, N., Blennow, K., & Zetterberg, H. (2016) · Brain Injury · doi:10.1080/02699052.2016.1179792 · Cited by 36
Metadata
- Authors
- Thomas, T., Thomas, G., McLendon, C., Sutton, T., & Mullan, M.
- Affiliations
- University of South Florida (US)
- Venue
- Nature
- Published
- 1996-03
- Volume
- 380
- Issue
- 6570
- Pages
- 168-171
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1990427131
- Cited by
- 703
- References
- 12
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 18 · 2023: 22 · 2022: 9 · 2021: 15 · 2020: 24 · 2019: 19 · 2018: 5 · 2017: 12 · 2016: 22 · 2015: 26 · 2014: 16 · 2013: 26 · 2012: 13
- FWCI
- 26.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- amyloid-beta, Alzheimer's disease, vascular endothelial cells, superoxide, free radicals, superoxide dismutase, endothelium-derived relaxing factor, lipid peroxidation, vascular tone, neurodegeneration, aging, oxidative stress
- MeSH terms
- Acetylcholine, Alzheimer Disease, Animals, Aorta, Blood Vessels, Endothelium, Vascular, Nerve Degeneration, Phenylephrine, Superoxides, Vasoconstriction, Vasoconstrictor Agents, Vasodilator Agents, Amyloid beta-Peptides, Rats, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.